featured
Efficacy of 6-Week vs 3-Month Anticoagulant Therapy in Young Patients With Provoked VTE
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism - The Kids-DOTT Randomized Clinical Trial
JAMA 2022 Jan 11;327(2)129-137, NA Goldenberg, JM Kittelson, TC Abshire, M Bonaca, JF Casella, RA Dale, JL Halperin, F Hamblin, CM Kessler, MJ Manco-Johnson, RF Sidonio, AC Spyropoulos, PG Steg, AGG Turpie, S SchulmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.